For the first time, it is found that natural compound coptisine can stabilize the ATF4‐G4 and subsequently disrupt its interaction with transcription factor TFAP2A, ultimately restoring the effectiveness of glutamine‐restricted cancer therapies. The gene discussed is TFAP2A; the disease is cancer.